MediWound Ltd.: MediWound Initiates the VALUE Global Phase III Pivotal Trial of EscharEx for Treatment of Venous Leg Ulcers
Phase III trial to assess the efficacy and safety of EscharEx® for debridement and facilitation of active wound closure Interim analysis planned after 65% of patients complete treatment, expected in ...
TMCnet10h
MediWound Initiates the VALUE Global Phase III Pivotal Trial of EscharEx® for Treatment of Venous Leg Ulcers
YAVNE, Israel, Feb. 12, 2025 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), a global leader in next-generation enzymatic therapeutics for tissue repair, today announced the initiation of VALUE, a ...
clinicalpainadvisor.com1d
GI Involvement in EGPA Linked to Eosinophilic Tissue Infiltration, Weight Loss
Gastrointestinal involvement is common among patients with EGPA, with eosinophilic tissue infiltration, weight loss, and ...
Miami Herald14d
Doctors hide thumb bone in man’s arm after work injury, then use it to build new one
The infection finally was “controlled,” doctors said, and the first signs of healing appeared as granulation tissue in the wound. The 25-year-old went back into the operating room, and doctors ...